Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.1900 (1.43%) ($3.1900 - $3.1900) on Mon. Feb. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.63% (three month average) | RSI | 28 | Latest Price | $3.1900(1.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -6.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(87%) IWO(84%) ARKG(82%) ARKK(82%) SKYY(82%) | Factors Impacting CGEN price | CGEN will decline at least -2.315% in a week (0% probabilities). VIXM(-73%) VXX(-54%) UUP(-27%) UNG(-11%) GLD(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.315% (StdDev 4.63%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-13.83(-533.54%) | Resistance Level | $3.6 | 5 Day Moving Average | $3.26(-2.15%) | 10 Day Moving Average | $3.35(-4.78%) | 20 Day Moving Average | $3.6(-11.39%) | To recent high | -55.5% | To recent low | 2.9% | Market Cap | $264m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |